Evidence map›Paper›PMID 38469458›Full record

ArticleHemaSphere2024

IDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantation.

Adrien Caillet, Marion Simonet-Boissard, Edouard Forcade, Marie Robin, Marie-Thérèse Rubio, Marie-Anne Couturier, Micha Srour, Natacha Maillard, Raynier Devillier, Anne Huynh and 7 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 13 institutions in 1 country.

Adrien CailletHematology Department, Hôpital Jean Minjoz CHU Besançon Besançon France.
Marion Simonet-BoissardHematology Department, Hôpital Jean Minjoz CHU Besançon Besançon France.
Edouard ForcadeHematology Department, Hôpital Haut-Lévêque CHU Bordeaux Bordeaux France.
Marie RobinHematology Department Hôpital Saint-Louis Paris France.
Marie-Thérèse RubioHematology Department, Hôpital Brabois CHU Nancy Nancy France.
Marie-Anne CouturierHematology Department CHU Brest Brest France.
Micha SrourHematology Department, CHU de Lille University of Lille Lille France.
Natacha MaillardHematology Department CHU Poitiers Poitiers France.
Raynier DevillierHematology Department Institut Paoli-Calmettes Marseille France.
Anne HuynhHematology Department IUCT Oncopole Toulouse France.
Jean-Henri BourhisHematology Department Institut Gustave Roussy Villejuif France.
Célestine SimandHematology Department, ICANS CHU Strasbourg Strasbourg France.
Sylvain ChantepieHematology Department CHU Caen Caen France.
Cyril BoissonMethodological and Quality of Life in Oncology Unit, University Hospital of Besançon, Franche-Comté University, INSERM, Etablissement Français du Sang Bourgogne Franche-Comté, UMR 1098 Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique Besançon France.
Marie KroemerPharmacy Department, INSERM, Etablissement Français du Sang, Bourgogne Franche Comté, UMR 1098 Interactions Hôte-Greffon-Tumeur/Inginérie Cellulaire et Génique Besançon France.
Eric DeconinckHematology Department Centre Hospitalier Universitaire de Besancon Besançon France.ORCID 0000-0002-6006-8088
Ana BerceanuHematology Department, Hôpital Jean Minjoz CHU Besançon Besançon France.
Inserm · FRCentre Hospitalier Régional et Universitaire de Nancy · FRCentre Hospitalier Régional Universitaire de Brest · FRCentre Hospitalier Universitaire de Besançon · FRCentre Hospitalier Universitaire de Caen Normandie · FRCentre Hospitalier Universitaire de Poitiers · FRHôpital Cardiologique du Haut-Lévêque · FRHôpital Saint-Louis · FRInstitut de Cancérologie Strasbourg · FRInstitut Gustave Roussy · FRInstitut Paoli-Calmettes · FRInstitut universitaire du cancer de Toulouse Oncopole · FRUniversité de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38469458
PMCPMC10925725
OpenAlexW4392658064

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.